In Caucasian subjects, pulse rate increased by 14.6, 10.5, and 2.8 bpm with semaglutide 0.5, 1.0 mg, and placebo, respectively
Patients with gastroparesis, severe kidney disease, or a personal or family history of medullary thyroid cancer are generally not good candidates for Zepbound
During your visit, your Klinic provider will explain how oral Wegovy works and personalize your treatment plan based on your medical history and weight loss goals
Wegovy might cause blood clots through mechanisms like altered blood coagulation, inflammation, dehydration, and changes in blood flow
For those whove achieved their weight loss objectives and are looking to maintain results, discussions about extending treatment or transitioning to a weight maintenance plan should take place with their doctor